VanEck Associates’s Protolabs PRLB Stock Holding History

VanEck Associates’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-140	Closed	-$17K	–	1305
2021 Q1	$17K	Buy	+140	New	+$23.3K	﹤0.01%	1192

Other funds holding PRLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

VanEck Associates's PRLB Position: Q2 2021 in Review

VanEck Associates sold out of Protolabs (PRLB) in Q2 2021, closing a stake of 140 shares — an estimated $17K sold.

VanEck Associates first reported a position in PRLB in Q1 2021 and held it in 1 quarter. The position peaked at $17K in Q1 2021. 273 funds tracked by Wall St. Rank hold PRLB as of Q2 2021.

VanEck Associates reported no remaining Protolabs position as of Q2 2021 after selling out during the quarter.
VanEck Associates sold 140 Protolabs shares in Q2 2021, an estimated $17K.
VanEck Associates first reported a position in Protolabs in Q1 2021 and held it in 1 quarter.
VanEck Associates's Protolabs position peaked at $17K in Q1 2021.
273 funds tracked by Wall St. Rank held Protolabs as of Q2 2021.

Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.